BGM Group/$BGM
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About BGM Group
BGM Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium. Maximum revenue is from Oxytetracycline & Licorice and TCMD, followed by Heparin products and Sausage casing.
- Ticker
- $BGM
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- -
- Headquarters
- Chengdu, China
- Website
- www.bgmgroupltd.com
BGM Group Metrics
BasicAdvanced
$107M
-
-$3.36
-
-
Price and volume
Market cap
$107M
52-week high
$10.80
52-week low
$6.45
Financial strength
Current ratio
1.25
Quick ratio
0.528
Long term debt to equity
0
Total debt to equity
0.003
Interest coverage (TTM)
-991.63%
Profitability
EBITDA (TTM)
-9.248
Gross margin (TTM)
16.92%
Net profit margin (TTM)
-44.22%
Operating margin (TTM)
-23.42%
Effective tax rate (TTM)
-28.77%
Management effectiveness
Return on assets (TTM)
-2.18%
Return on equity (TTM)
-7.41%
Valuation
Price to revenue (TTM)
1.06
Price to book
0.13
Price to tangible book (TTM)
1.59
Price to free cash flow (TTM)
34.153
Free cash flow yield (TTM)
2.93%
Free cash flow per share (TTM)
0.235
Growth
Revenue change (TTM)
78.43%
Earnings per share change (TTM)
-23.12%
Upcoming events
No upcoming events
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.